SEC Filings

< Back

SEC Filing Details

Document Details

Form

Proxy Statement for Annual General Meeting to be held on April 13, 2021

Filing Date

Mar 5, 2021

Document Date

Mar 5, 2021

Form Description

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Filing Group

Current Reports

Company

Polypid

Issuer

PolyPid Ltd.

Filing Formats

View HTML

Download PDF

Download DOC

Download XLS

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

D-PLEX₁₀₀

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

D-PLEX₁₀₀₀

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.